Results 41 to 50 of about 522,058 (284)

Pharmaceutical patents and the right to health – Portugal and Brazil (Vol.13, N.1)

open access: yesJanus.net, 2022
The defence of the patent system's legitimacy, namely in the pharmaceutical field, is consolidated, although it is not exempt from criticism. Historically, when the patent law, a legal monopoly right, is confronted with the right of access to
Ruben Bahamonde Delgado
doaj   +1 more source

Pazopanib Combined With Vincristine and Irinotecan in Relapsed Wilms Tumor: Encouraging Outcomes in a Heavily Pretreated Pediatric Cohort

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background While Wilms tumor (WT) typically has a favorable prognosis, relapsed cases—especially those with high‐risk histology—remain therapeutically challenging after intensive frontline therapy. The combination of vincristine and irinotecan has demonstrated activity in pediatric solid tumors, and pazopanib, a multi‐targeted tyrosine kinase ...
Maria Debora De Pasquale   +6 more
wiley   +1 more source

Towards “Zero by 30”, the Kenyan case: a systematic exploration of barriers to rabies policy implementation through systems thinking

open access: yesHealth Research Policy and Systems
Introduction Rabies is a neglected tropical disease (NTD) that disproportionately affects marginalized communities, despite the availability of effective vaccines.
Laurent Smets   +6 more
doaj   +1 more source

A multi-country survey on access to healthcare and treatment services among individuals with critical medical care needs during the first wave of the pandemic

open access: yesBMC Public Health, 2023
Background Healthcare services were significantly interrupted during the early phase of the COVID-19 pandemic. The aim of the present study was to determine the associations between sociodemographic factors and healthcare access during the first wave of ...
Morenike Oluwatoyin Folayan   +15 more
doaj   +1 more source

Essential medicines and access to insulin [PDF]

open access: yesThe Lancet Diabetes & Endocrinology, 2017
We fully support the views expressed in The Lancet Diabetes & Endocrinology's Editorial about ensuring affordable access to insulin and the proposal to add analogue insulin to the WHO Essential Medicines list. The International Insulin Foundation in its 2011 position statement called for “the universal access for persons with type 1 diabetes to life ...
Gill, Geoff   +8 more
openaire   +3 more sources

The right to health as the basis for universal health coverage : a cross-national analysis of national medicines policies of 71 countries [PDF]

open access: yes, 2019
Persistent barriers to universal access to medicines are limited social protection in the event of illness, inadequate financing for essential medicines, frequent stock-outs in the public sector, and high prices in the private sector.
Alexandrov, Nikita V   +2 more
core   +2 more sources

Potential Early Risk Biomarkers for Reduced Forced Expiratory Volume in Children Post‐Hematopoietic Cell Transplantation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT We sought to identify potential early risk biomarkers for lung disease in children post‐allogeneic HCT. Patients with pulmonary function tests 3 months post‐transplant and plasma samples between days 7 and 14 post‐HCT were included. Six of 27 subjects enrolled had reduced forced expiratory volume 1 (FEV1) z scores.
Isabella S. Small   +3 more
wiley   +1 more source

Integrating pharmaceutical systems strengthening in the current global health scenario: three ‘uncomfortable truths’

open access: yesJournal of Pharmaceutical Policy and Practice, 2020
The response to emergency public health challenges such as HIV, TB, and malaria has been successful in mobilising resources and scaling up treatment for communicable diseases.
Tamara Hafner   +8 more
doaj   +1 more source

International Assistance and Cooperation for Access to Essential Medicines [PDF]

open access: yes, 2010
Access to essential medicines is a critical problem that plagues many developing countries. With a daunting number of domestic constraints technologically, economically, and otherwise developing countries are faced with a steep uphill battle to meet the ...
Mok, Emily A.
core   +1 more source

Challenge and co-operation: civil society activism for access to HIV treatment in Thailand. [PDF]

open access: yes, 2009
Civil society has been a driving force behind efforts to increase access to treatment in Thailand. A focus on HIV medicines brought civil society and non-governmental and government actors together to fight for a single cause, creating a platform for ...
Ainsworth   +30 more
core   +2 more sources

Home - About - Disclaimer - Privacy